Insight & Intelligence

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 15, 2009 (Vol. 29, No. 4)

New Antibody Engineering Technologies

More Effective and Targeted Therapeutics Viewed As Anticipated Outcomes

  • New approaches to antibody engineering were presented at the “European Antibody Congress” held in Geneva, Switzerland last month. At the meeting, companies grappled with long-standing issues of glycosylation, antibody structures, alternative structures, and novel purification approaches. While the mechanism of tumor-cell destruction by therapeutic antibodies is not completely ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Be sure to take the GEN Poll

{{ vm.poll.Title }}

More »